Lacticaseibacillus paracasei KBL382 contributes to the immunomodulation in THP-1 cells
Journal of Microbiology · 2026
DOI: 10.71150/jm.2509016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, 2026. Verfasst von MinJoong Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea. Hauptthemen laut MEDLINE: Immunomodulation, Lacticaseibacillus paracasei, Probiotics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Ministry of Science and ICT.
Abstract (Originalsprache)
Gut microbiome imbalance can induce inflammatory responses via Toll-like receptor 2 (TLR2) signaling pathways. Lactobacillus spp., popularly applied as probiotics in both humans and animals, have come into the spotlight for their strong immunomodulatory effects. We aimed to evaluate the immunomodulatory potential of live or pasteurized Lacticaseibacillus paracasei (L. paracasei) KBL382, isolated from healthy Korean individuals, in an in vitro monocytic THP-1 cell model. Live L. paracasei KBL382 significantly increased TLR2 and MyD88 expressions and induced IRAK1 expression, irrespective of lipopolysaccharide (LPS) stimulation (p < 0.05). Under LPS stimulation, THP-1 cells treated with live L. paracasei KBL382 showed significantly increased interleukin (IL)-6 and IL-10 levels (p < 0.05). Pasteurized L. paracasei exhibited a decrease in IL-12 levels (p < 0.05). Moreover, live L. paracasei KBL382 also markedly elevated A20 and SOCS1 expressions, the critical negative regulators of inflammation, regardless of LPS stimulation (p < 0.05). The expression of IRAK3, another negative regulator of inflammation, was increased in THP-1 cells with live L. paracasei KBL382 under LPS stimulation (p < 0.05). Our findings demonstrate that L. paracasei KBL382 contributes to the immunomodulation in THP-1 cells by coordinating both positive and negative regulatory signaling. L. paracasei KBL382 could be used as a promising probiotic strain for attenuating chronic inflammation through the gut-immune axis mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.
- N-Bio, Seoul National University, Seoul 08826, Republic of Korea.
- KoBioLabs, Inc., Seoul 08826, Republic of Korea.
- weBiom Inc., Seoul 08826, Republic of Korea.
- Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea.
- Brain Korea for Global Leader of Better Environmental health (BK4GLOBE), Seoul National University, Seoul 08826, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Education
- Ministry of Science and ICT
Zitieren
APA
Kim, M., Jo, M. J., Park, S., Lee, S. B., Jang, S. J., Lee, C., Kim, W. K., & Ko, G. (2026). Lacticaseibacillus paracasei KBL382 contributes to the immunomodulation in THP-1 cells. Journal of Microbiology. https://doi.org/10.71150/jm.2509016
Vancouver
Kim M, Jo MJ, Park S, Lee SB, Jang SJ, Lee C, et al. Lacticaseibacillus paracasei KBL382 contributes to the immunomodulation in THP-1 cells. Journal of Microbiology. 2026. doi:10.71150/jm.2509016
BibTeX
@article{Kim2026,
author = {Kim, MinJoong and Jo, Min Jung and Park, SungJun and Lee, Seoung Bum and Jang, Sung Jae and Lee, Cheonghoon and Kim, Woon-Ki and Ko, GwangPyo},
title = {Lacticaseibacillus paracasei KBL382 contributes to the immunomodulation in THP-1 cells},
journal = {Journal of Microbiology},
year = {2026},
doi = {10.71150/jm.2509016}
}
EUVIMED